Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.93, $0.08 better than the analyst estimate of $0.85. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.21 billion.

GUIDANCE:

Encompass Health Corporation sees FY2021 EPS of $3.31-$3.53, versus the consensus of $3.83. Encompass Health Corporation sees FY2021 revenue of $5-5.17 billion, versus the consensus of $5.06 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.